Seratrodast
Product Specifications
CAS Number
112665-43-7
Target
Reactive Oxygen Species, Ferroptosis, JNK, MDM-2/p53, COX, Prostaglandin Receptor, ROS, PPAR
Related Pathways
GPCR/G Protein, NF-κB, Neuroscience, MAPK, Metabolism, DNA Damage/DNA Repair, Immunology/Inflammation, Apoptosis
Purity
0.9969
Bioactivity
Seratrodast (ABT-001) (INN), a thromboxane A2 (TXA2) receptor (TP receptor) antagonist, is mainly used in the therapy of asthma. It was the first TP receptor antagonist developed as an anti-asthmatic drug and attained marketing qualification in Japan in 1997.
Smiles
C(CCCCCC(O)=O)(C1=C(C)C(=O)C(C)=C(C)C1=O)C2=CC=CC=C2
Molecular Formula
C22H26O4
Molecular Weight
354.44
Shipping Conditions
Ice Packs
Storage Temperature
-20°C
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
LH07929V 100 µg
TRIP (TRAIP) (NM_005879) Human Over-expression Lysate
Sign In for Pricing
View Details 
MBS6377981-01 0.1 mL
FADS1 (Fatty Acid Desaturase 1, Delta(5) Fatty Acid Desaturase, D5D, Delta(5) Desaturase, Delta-5 Desaturase, FADSD5, FLJ38956, FLJ90273) (MaxLight 405)
Sign In for Pricing
View Details MBS6377981-02 5x 0.1 mL
FADS1 (Fatty Acid Desaturase 1, Delta(5) Fatty Acid Desaturase, D5D, Delta(5) Desaturase, Delta-5 Desaturase, FADSD5, FLJ38956, FLJ90273) (MaxLight 405)
Sign In for Pricing
View Details 
